Robert Taub

Robert Taub is a serial entrepreneur and investor in several pharmaceutical and medical device companies. He gained an MBA at INSEAD and held various general management and sales and marketing positions with Monsanto, Baxter Travenol Laboratories and the Revlon Health Care Group.

Mr. Taub later became an entrepreneur in the pharmaceutical and medical fields in the 1980's. Prior to Nyxoah he co-founded and co-managed Octapharma, a human plasma protein company for 12 years. He also founded and managed Omrix Biopharmaceuticals throughout a NASDAQ IPO followed by the acquisition by Johnson & Johnson. He was an early investor and chairman of Neuroderm, a Parkinson’s disease pharmaceutical company, throughout its IPO on NASDAQ and later sale to Mitsibushi-Tanabe.